Camrelizumab‐induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab‐induced erythema multiforme in a patient with acute myeloid leukemia-Reference-Cited by-同舟云学术

Camrelizumab‐induced reactive cutaneous capillary endothelial proliferation followed by tislelizumab‐induced erythema multiforme in a patient with acute myeloid leukemia

Published:2023-11-29 Issue:2 Volume:63 Page:251-253
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatology

Author:

Hui Hai‐Zhen¹,Guo Hong‐Xing²,Wang Ying‐Jun¹,Yu Yin¹,Liu Yu‐Xiang³,Liu Hua¹,Shi Bing‐Jun¹^ORCID

Affiliation:

1. Department of Dermatology Chongqing Hospital of Traditional Chinese Medicine (Chongqing Clinical Research Center for Dermatology; Chongqing Key Laboratory of Integrative Dermatology Research) Chongqing P.R. China

2. Department of General Surgery Chongqing Hospital of Traditional Chinese Medicine Chongqing P.R. China

3. The Second People's Hospital of Guizhou Province Guiyang P.R. China

Funder

Natural Science Foundation of Chongqing

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.16945

Reference5 articles.

2. Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

3. Tislelizumab: an investigational anti-PD-1 antibody for the treatment of advanced non-small cell lung cancer (NSCLC)

4. Recurrent erythema multiforme induced by the combination of pembrolizumab and radiation;Ambur AB;Cureus,2021

5. Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab/tislelizumab;Reactions Weekly;2024-02-17